NEDD4L and plasma cell myeloma: Huang et al. reported that suppression of NEDD4L expression diminished the sensitivity of multiple myeloma to bortezomib, which was mainly mediated by low NEDD4L expression via autophagy inhibition (Huang et al., 2022).